PP_1170x120_10-25-21

Rhofade

Allergan readies launch of Rhofade rosacea cream

Allergan readies launch of Rhofade rosacea cream

DUBLIN, Ireland — Allergan plc is set to release Rhofade oxymetazoline hydrochloride cream 1%, a topical medication to help treat rosacea. Indicated for persistent facial erythema, or redness, associated with rosacea in adults, Rhofade adds brings a once-daily solution to the few alternatives available for the treatment of this rosacea symptom, Allergan said. Plans call

Adheris Health